Can MedGenome use genetics to predict cancer? VCs bet $4M on it

The Indian cancer genetic research company MedGenome says it has taken $4 million in new funding to further develop and market its genetic sequencing research on cancer victims. MedGenome licenses a bioinformatics database called OncoMD, which contains more than 1.2 ...